KRSNAA Stock Overview
Provides diagnostic services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Krsnaa Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹972.25 |
| 52 Week High | ₹981.80 |
| 52 Week Low | ₹528.05 |
| Beta | -0.16 |
| 11 Month Change | 20.76% |
| 3 Month Change | 34.34% |
| 1 Year Change | 54.25% |
| 33 Year Change | 37.22% |
| 5 Year Change | n/a |
| Change since IPO | -1.49% |
Recent News & Updates
Recent updates
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17Shareholder Returns
| KRSNAA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 6.7% | 0.4% | -1.2% |
| 1Y | 54.3% | 37.9% | 25.5% |
Return vs Industry: KRSNAA exceeded the Indian Healthcare industry which returned 37.9% over the past year.
Return vs Market: KRSNAA exceeded the Indian Market which returned 25.5% over the past year.
Price Volatility
| KRSNAA volatility | |
|---|---|
| KRSNAA Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: KRSNAA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: KRSNAA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3,700 | Mitesh Dave | krsnaadiagnostics.com |
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers.
Krsnaa Diagnostics Limited Fundamentals Summary
| KRSNAA fundamental statistics | |
|---|---|
| Market cap | ₹31.39b |
| Earnings (TTM) | ₹692.15m |
| Revenue (TTM) | ₹6.81b |
45.4x
P/E Ratio4.6x
P/S RatioIs KRSNAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KRSNAA income statement (TTM) | |
|---|---|
| Revenue | ₹6.81b |
| Cost of Revenue | ₹1.75b |
| Gross Profit | ₹5.06b |
| Other Expenses | ₹4.37b |
| Earnings | ₹692.15m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 21.44 |
| Gross Margin | 74.24% |
| Net Profit Margin | 10.16% |
| Debt/Equity Ratio | 20.1% |
How did KRSNAA perform over the long term?
See historical performance and comparison